Why is "FDA Adverse Event Reporting System" trending?

Search Interest Perspective

• Evaluating the Evolving Real-World Adverse Events of GLP-1RAs Using FDA Adverse Event Reporting System (FAERS) - onlinelibrary.wiley.com
• Tofacitinib safety in inflammatory bowel disease: a disproportionality analysis of the FDA adverse event reporting system - Springer Nature Link
• Safety evaluation of selective estrogen receptor degraders (SERDs) using real-world evidence from the FDA Adverse Event Reporting System (FAERS) - Nature
• Comparative Pharmacovigilance Analysis of Cardiovascular Adverse Events Associated With Tezepelumab vs Dupilumab in Asthma Patients Using the FDA Adverse Event Reporting System - Cureus
• Statin use and the risk of tubulointerstitial nephritis: a real-world signal detection analysis using FDA Adverse Event Reporting System - frontiersin.org
• Drugs Recognized as Potential Maculopathy Risk Factors - Review of Optometry
• Drug-related retinal detachment pharmacovigilance signals in the real world: evidence from the FDA Adverse Event Reporting System | Eye - Nature
• FDA Now Providing Daily Updates on Adverse Events - Neurology Advisor
• April - June 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS) - EIN Presswire
• Recognizing potential immune checkpoint inhibitor-associated optic neuritis: insights from the FDA adverse event reporting system - Springer Nature Link
• Drug‐induced respiratory depression in FDA Adverse Event Reporting System for 20 years - onlinelibrary.wiley.com
• Pharmacovigilance evidence of drug induced urinary incontinence in the FDA adverse event reporting system - Nature
• A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting system - Nature
• A comprehensive study on drug-related Raynaud’s phenomenon based on the FDA adverse event reporting system - Nature
• A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system - Nature
• A pharmacovigilance study of vortioxetine based on data from the FDA adverse event reporting system - Nature
• Pharmacovigilance of drug-induced cataract using the FDA Adverse Event Reporting System - Nature
• A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database - Nature
• Safety comparisons among different subcutaneous anticoagulants for venous thromboembolism using FDA adverse event reporting system - Nature
• A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab - frontiersin.org
• A realworld pharmacovigilance study of trazodone based on the FDA adverse event reporting system - Nature
• A disproportionality analysis of FDA adverse event reporting system events for misoprostol - Nature
• FDA debuts online dashboard for cosmetic adverse event tracking - Premium Beauty News
• Mortality and Serious Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists: A Pharmacovigilance Study Using the FDA Adverse Event Reporting System - Cureus
• Real-World pharmacovigilance analysis of drug-related conjunctivitis using the FDA adverse event reporting system database - Nature
• Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database - Nature
• A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag - Nature
• Safety comparisons among monoamine oxidase inhibitors against Parkinson’s disease using FDA adverse event reporting system | Scientific Reports - Nature
• Assessment of drug induced hyperuricemia and gout risk using the FDA adverse event reporting system - Nature
• Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database - Nature
• Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system - Nature
• A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617 - Nature
• Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system - Nature
• Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system - Nature
• Possible adverse events of imidazole antifungal drugs during treatment of vulvovaginal candidiasis: analysis of the FDA Adverse Event Reporting System - Nature
• A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib | Scientific Reports - Nature
• Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System - Nature
• A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database - frontiersin.org
• Pharmacovigilance study of the association between peripheral neuropathy and antibody–drug conjugates using the FDA adverse event reporting system - Nature
• Pharmacovigilance study of the association between progestogen and depression based on the FDA adverse event reporting System (FAERS) - Nature
• Long-term hepatobiliary disorder associated with trastuzumab emtansine pharmacovigilance study using the FDA Adverse Event Reporting System database - Nature
• FDA rolls out daily updates to adverse event dashboard, plans to further 'streamline' system - Fierce Pharma
• Pharmacovigilance analysis of immune checkpoint inhibitor-related reproductive adverse effects based on the FDA adverse event reporting system | Scientific Reports - Nature
• Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system - Nature
• Ophthalmic Corticosteroids-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) Database pharmacovigilance study - frontiersin.org
• A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins - Nature
• A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib - Nature
• Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database - Nature
• Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system - Nature
• A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system - Nature
• Standardization of drug names in the FDA Adverse Event Reporting System: The DiAna dictionary - medRxiv
• Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system - Nature
• A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib - frontiersin.org
• A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib - Nature
• A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam - frontiersin.org
• A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system - frontiersin.org
• An investigation of drug-induced mental disorders in the children and adolescents population utilizing the FDA adverse event reporting system - Nature
• Dasatinib-Associated Chylothorax: A Review of Cases Reported to the FDA Adverse Event Reporting System and the Published Literature - Springer Nature Link
• A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS) - Nature
• Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the FDA Adverse Event Reporting System - clinicaladvisor.com
• A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data - Nature
• Psychiatric safety associated with hormone replacement therapy for menopausal symptoms: a real-world study of the FDA adverse event reporting system - frontiersin.org
• Association between voriconazole-induced visual hallucination and dopamine in an analysis of the food and drug administration (FDA) adverse event reporting system database - Nature
• An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study - Nature
• A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database - Nature
• Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system - frontiersin.org
• Pharmacovigilance study of the association between dipeptidyl peptidase–4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS) - Nature
• Hematological toxicities in PARP inhibitors: A real-world study using FDA adverse event reporting system (FAERS) database - onlinelibrary.wiley.com
• Comparison of safety of lecanemab and aducanumab: a real-world disproportionality analysis using the FDA adverse event reporting system - frontiersin.org
• Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system | Scientific Reports - Nature
• Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system - frontiersin.org
• SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System - The Lancet
• Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS) - frontiersin.org
• Healthcare analytics sandbox: Load and analyze FDA Adverse Event Reporting System data with Neo4j - Neo4j
• Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system - frontiersin.org
• Cardiac arrhythmias associated with immune checkpoint inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system - frontiersin.org
• Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system - frontiersin.org
• Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System - frontiersin.org
• Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System - Nature
• An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database - Springer Nature Link